Amphastar Pharmaceuticals... (AMPH)
NASDAQ: AMPH
· Real-Time Price · USD
30.19
-0.29 (-0.95%)
At close: Aug 14, 2025, 3:59 PM
30.21
0.07%
Pre-market: Aug 15, 2025, 08:45 AM EDT
-0.95% (1D)
Bid | 28.82 |
Market Cap | 1.4B |
Revenue (ttm) | 728.26M |
Net Income (ttm) | 141.63M |
EPS (ttm) | 2.67 |
PE Ratio (ttm) | 11.31 |
Forward PE | 6.76 |
Analyst | Hold |
Ask | 30.25 |
Volume | 386,620 |
Avg. Volume (20D) | 542,938 |
Open | 30.03 |
Previous Close | 30.48 |
Day's Range | 29.64 - 30.63 |
52-Week Range | 20.39 - 53.96 |
Beta | 0.76 |
About AMPH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AMPH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AMPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Amphastar Pharmaceuticals has released their quartely earnings
on Aug 7, 2025:
Next Earnings Release
Amphastar Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 days ago
+10.93%
Amphastar Pharma shares are trading higher after N...
Unlock content with
Pro Subscription
3 days ago
+14.91%
Amphastar Pharmaceuticals shares are trading higher after the company announced FDA approval for its iron sucrose injection.

3 days ago · accessnewswire.com
Amphastar Announces FDA Approval for Iron Sucrose Injection, USPAccording to the FDA, Amphastar's iron sucrose injection meets the criteria for bioequivalence and therapeutic equivalence to Venofer ® for the treatment of iron deficiency anemia in patients with chr...

2 weeks ago · seekingalpha.com
Amphastar Pharmaceuticals: Shares Are Interesting, And Options Even MoreAmphastar is undervalued (~71% upside), but lacks an economic moat and faces modest growth, so I favor a cautious gradual strategy. The business is defensive, with a diversified product mix and pipeli...